Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Testing the Effect of an Anticancer Drug, Onvansertib, in Advanced-Stage Small Cell Lung Cancer

Trial Status: temporarily closed to accrual

This phase II study evaluates the safety and effectiveness of onvansertib for the treatment of patients with small cell lung cancer. Onvansertib is an enzyme inhibitor that disrupts cell replication and induces tumor cell death by binding to a receptor called PLK1, which is crucial for the regulation of cell replication, and plays a key role in tumor cell proliferation.